Updated Jul 16, 2026
Chaubey Alka has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Alka Chaubey is the Chief Medical Officer at Bionano Genomics, Inc., a company focused on genome analysis and structural variation detection. She has been involved in the life sciences sector, contributing to the development of diagnostic and therapeutic solutions.
| Role | Insider |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-04 | BNGO | Bionano Genomics, Inc. | F — Tax withholding / forfeiture | 24 | $1.30 | $31 |
| 2026-02-18 | BNGO | Bionano Genomics, Inc. | F — Tax withholding / forfeiture | 18 | $1.10 | $20 |
| 2025-09-11 | BNGO | Bionano Genomics, Inc. | F — Tax withholding / forfeiture | 51 | $4.06 | $207 |
Alka Chaubey is the Chief Medical Officer at Bionano Genomics, Inc., a company focused on genome analysis and structural variation detection. She has been involved in the life sciences sector, contributing to the development of diagnostic and therapeutic solutions.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Chaubey Alka profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.